Company intelligence / Profile preview

Lumibird

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

Lumibird is a global leader in laser technologies with over five decades of experience. Its medical division, Lumibird Medical, provides innovative diagnostic and therapeutic tools for ophthalmology and interventional imaging. The company’s products are widely used in clinical practice for the treatment of cataracts, glaucoma, dry eye disease, AMD, and in minimally invasive procedures through advanced imaging solutions.

Therapeutic areas: OtherOphthalmology
Modalities: DeviceMedical lasersDiagnostic imaging devices
Industry: Medical Imaging

Partnerships

Agreement to acquire nanosecond laser product line from Amplitude Laser Group under the Continuum brand.

Beyond the preview

Go deeper on Lumibird.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lumibird.

Explore the full profile